Altre lingue Arch Therapeutics, Inc.

Azioni

ARTH

US03939W2089

Mercato chiuso - OTC Markets Altri mercati azionari 19:58:30 24/04/2024			Variaz. 5gg	Var. 1 gen.
1,18 ^USD	+3,51%		0,00%	-83,70%

20/02	Arch Therapeutics, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 dicembre 2023	CI
15/02	Arch Therapeutics, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Arch Therapeutics : New Financial Obligation - Form 8-K	03/04
Arch Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	20/02
Arch Therapeutics, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	15/02
Arch Therapeutics : New Financial Obligation - Form 8-K	15/12
Arch Therapeutics Provides Year End Operational Update	09/11
Arch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)	02/11
Arch Therapeutics, Inc. to Present AC5®? Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)	02/11
Arch Therapeutics, Inc. Provides Commercialization Update on the First Product, AC5 Advanced Wound System	13/09/23
Arch Therapeutics Provides AC5® Commercialization Update	13/09/23
Arch Therapeutics Completes Financing as Bridge to Uplisting	08/09/23
Arch Therapeutics, Inc. announced that it has received $2.560063 million in funding	31/08/23
Arch Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	11/08/23
Arch Therapeutics, Inc. announced that it expects to receive $1.850001 million in funding	07/07/23
Arch Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23/05/23
Arch Therapeutics to Present AC5(R) Advanced Wound System At 2023 Symposium on Advanced Wound Care	25/04/23
Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)	25/04/23
Dedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In Effect	05/04/23
Arch Therapeutics, Inc. Announces Dedicated HCPCS Billing Code for its Advanced Wound System Now in Effect	05/04/23
Arch Therapeutics : Material Agreement - Form 8-K	17/03/23
Arch Therapeutics' AC5(R) Advanced Wound System Receives Dedicated HCPCS Billing Code from the Centers for Medicare & Medicaid Services	09/03/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Arch Therapeutics, Inc.

Azioni

ARTH

US03939W2089

Altre lingue

Filtri